Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Kofol SF is a proprietary, sugar-free Ayurvedic oral syrup developed and manufactured by Charak Pharma. Formulated specifically for diabetic patients and health-conscious individuals, it is a combination of medicinal herbal plants designed to alleviate dry and wet coughs, sore throat, throat irritation, the common cold, bronchial asthma-related cough, and cough associated with gastro-oesophageal reflux. Its key active herbal ingredients include Haridra (Turmeric), Yashtimadhu (Licorice), Vasaka (Malabar Nut), Kantakari (Indian Nightshade), Pippali (Long Pepper), Bibhitaki, Shunthi, and Tulsi (Holy Basil). These herbs act synergistically to provide anti-inflammatory, mucolytic, expectorant, anti-tussive, and immunomodulatory effects on the respiratory tract without causing drowsiness.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Kofol SF.